RSN 35 mg (Risedronate Sodium 35 mg)

Pill with imprint RSN 35 mg is Orange, Elliptical/Oval and has been identified as Risedronate Sodium 35 mg. It is supplied by Actavis Pharma, Inc.

Risedronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RSN 35 mg

Risedronate Sodium

Imprint: RSN 35 mg
Strength: 35 mg
Color: Orange
Shape: Elliptical/Oval
Availability: Prescription only
Drug Class: Bisphosphonates
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Actavis Pharma, Inc.
Inactive Ingredients: crospovidone, hydroxypropyl cellulose, hypromelloses, magnesium stearate, microcrystalline cellulose, polyethylene glycol, silicon dioxide, titanium dioxide, ferric oxide red, ferric oxide yellow, lactose monohydrate
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00591-2075 (Discontinued)	Watson Pharmaceuticals, Inc.
00430-0472	Warner Chilcott
54868-4671 (Discontinued)	Physicians Total Care Inc. (repackager)
54569-5462	A-S Medication Solutions, LLC (repackager)
49999-0448	Lake Erie Medical and Surgical Supply (repackager)